Users say this new wrinkle-smoothing retinol skincare transforms skin in just WEEKS: 'Smooth, supple and more youthful'
Beauty buffs looking to smooth fine lines and plump the skin fast are racing to shop the brand new High Potency Retinol skincare from Perricone MD, designed to deliver visible results in as little as one month.
Featuring a face and eye serum supercharged with a triple retinol blend, this new collection has been clinically proven to reduce signs of ageing without sensitivity – and you can score a freebie worth £82 when you snap up both products today.
Perricone MD Triple Retinol Renewal Eye Serum, 15ml £64
Perfect for making tired, lined eyes a thing of the past, the Triple Retinol Renewal Eye Serum works day and night to visibly reduce crow's feet, under-eye wrinkles and discolouration.
Working hard without the sensitivity of other retinol formulas, this supercharged eye serum also helps to visibly brighten and minimise dark circles and darkness for a more open, awakened look, all the while leaving skin deeply hydrated.
Shop
Perricone MD Triple Retinol Renewal Face Serum £83
The Triple Retinol Renewal Face Serum is set to be the transformative solution your skin has been looking for.
Similarly formulated with the brand's triple retinol blend, coenzyme Q10 and naturally derived betacarotene, this powerful day and night serum accelerates skin renewal with less sensitivity to deliver the look of collagen-rich, firmer skin.
Shop
Perfect for making tired, lined eyes a thing of the past, the Triple Retinol Renewal Eye Serum works day and night to visibly reduce crow's feet, under-eye wrinkles and discolouration
That's right, when you shop the Perricone MD Triple Retinol Renewal Eye Serum and face serum, you'll receive a full-size Retinol Recovery Overnight Moisturizer 59ml (worth £82) for free, giving you all the tools you need for flawless skin.
Creating luxury skincare products backed by powerful ingredients, cutting-edge research and extensive clinical and consumer studies, Perricone MD is the place to shop if you're looking for real results.
Designed for those seeking visibly smoother, firmer and more refined skin, the new advanced Triple Retinol blend collection has been made with a proprietary formulation of three distinct forms of retinol, offering powerful results while minimising irritation.
Unlike traditional formulas, Triple Retinol delivers gradual, controlled release to help target fine lines, uneven tone and texture – making it ideal for both new and experienced retinol users.
And it's this Triple Retinol blend that powers the brand new eye and face serum, creating the perfect two-step routine for smoother, more youthful-looking skin.
Perfect for making tired, lined eyes a thing of the past, the Triple Retinol Renewal Eye Serum works day and night to visibly reduce crow's feet, under-eye wrinkles and discolouration.
Formulated with Perricone's proprietary triple retinol blend alongside antioxidant powerhouse coenzyme Q10 and naturally derived beta-carotene (vitamin A), this powerful eye serum accelerates skin renewal to reduce the look of under-eye puffiness and uneven texture for a firmer, smoother appearance.
Working hard without the sensitivity of other retinol formulas, this supercharged eye serum also helps to visibly brighten and minimise dark circles and darkness for a more open, awakened look, all the while leaving skin deeply hydrated.
In fact, in clinical trials on 34 women, 100 per cent showed significant improvement in skin hydration immediately after application, while after four weeks, 91 per cent showed a significant reduction in under-eye dark circles and 88 per cent showed a significant reduction in under-eye puffiness.
And to compliment the supercharged eye serum? The Triple Retinol Renewal Face Serum is set to be the transformative solution your skin has been looking for.
Similarly formulated with the brand's triple retinol blend, coenzyme Q10 and naturally derived betacarotene, this powerful day and night serum accelerates skin renewal with less sensitivity to deliver the look of collagen-rich, firmer skin.
Showing significant results fast, the impressive serum helps to visibly diminish uneven texture, dullness and redness for a more even, radiant complexion, absorbing instantly for added hydration and glow.
Clinical trials for the Triple Retinol Renewal Face Serum have been impressive, too, where when tested on 37 women, 76 per cent showed significant improvement in skin elasticity and resiliency in four weeks, and 78 per cent showed significant improvement in the feel of rough skin texture after eight weeks.
Seventy-sixper cent showed a significant reduction in fine lines on the cheek and a significant reduction in age and sunspots after eight weeks, too.
The brand recommend gently patting the eye serum onto the eye area in the morning and evening, then massaging the face serum onto the face and neck using a gentle upward motion.
Follow with moisturiser and, as always when starting with new retinol formulas, start by applying for 1-2 nights per week and increase gradually as tolerated.
Ready to upgrade your skincare routine? Snap up both Triple Retinol Renewal formulas and receive a free, top-selling Perricone MD HP Retinol Recovery Overnight Moisturiser worth £82.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Times
15 minutes ago
- Times
Test could identify women at increased risk of miscarriage
British scientists have developed a test that detects abnormalities in the womb lining, which could help identify women with an increased risk of suffering a miscarriage. It is hoped it will pave the way for more treatments to prevent repeated pregnancy losses. About one in six pregnancies are lost and the majority of these happen before 12 weeks. Each miscarriage increases the risk of another occurring. Charities said that the findings could help to provide an explanation for repeated miscarriages. According to the team from Warwick University, in some women the womb lining does not react as it should during pregnancy. The test they developed can measure signs of a healthy or defective reaction in the womb lining. It is now being piloted to help more than a thousand patients at Tommy's National Centre for Miscarriage Research at University Hospital Coventry & Warwickshire (UHCW).Dr Jo Muter, the lead author of the study and a researcher at Warwick Medical School, told the BBC: 'Many women are told they've just had 'bad luck', but our findings show that the womb itself may be setting the stage for pregnancy loss, even before conception takes place.'Much of the research in this area has focused on the embryo, rather than the womb hosting it. The womb lining during pregnancy undergoes a reaction, which converts the cells to a more supportive state. In cases where this does not happen or this reaction is faulty, the risk of bleeding and pregnancy loss increases. When a faulty reaction occurs, it is more likely to occur again, according to the research team. Dr Jyotsna Vohra, director of research at Tommy's, said that care and treatment for those who experienced pregnancy or baby loss varied unacceptably across the UK. 'There should be no barriers to accessing any test or treatment that has been proven to make a difference. 'We hope NHS decision-makers will look carefully at the results of the Coventry pilot project and consider rolling this test out nationwide, so that everyone who might benefit has that opportunity.' Vohra said that women suffering trauma after recurrent miscarriages were often 'left without answers', and that the test could offer some consolation by explaining the cause. The Warwick team analysed around 1,500 biopsies from more than 1,300 women for the study. Abnormal responses in the menstrual lining recurred across menstrual cycles for some women, suggesting a consistent cause of miscarriage risk which could be prevented. One of the women offered the new test, Holly Milkouris, said that it was 'life-changing' after she suffered five miscarriages. After the problems affecting her womb lining were detected and treated, Milkouris and her husband had two healthy children, now aged three and 17 months. Milkouris told The Guardian: 'We felt lost and were beginning to accept that I might never successfully carry a pregnancy. 'The treatments that typically can help women who have experienced miscarriages hadn't worked for us and each time we tried again we felt like we were rolling a dice with the baby's life. 'For the first time the results of my biopsy were normal, and we went on to have not one, but two successful pregnancies.'Muter said that the next step would be to use the test to assess potential drug treatments. Sitagliptin, a drug usually used to treat diabetes, is currently the go-to option for problems with the womb lining but Muter said that other existing drugs could be repurposed. Only 20 per cent of potential drugs are currently tested on pregnant women.
Telegraph
18 minutes ago
- Telegraph
Weight-loss jabs linked to pancreas problems after 10 deaths
Weight-loss jabs have been linked to pancreas problems after 10 patients died. Hundreds of people have reported problems with their pancreas linked to taking weight-loss and diabetes jabs including Mounjaro, Wegovy and Ozempic, prompting health officials to launch a new study into side effects. Ten cases of pancreatitis reported to be linked to GLP-1 medicines (glucagon-like peptide-1 receptor agonists) have been fatal. Since the GLP-1 medicines were licensed, there have been hundreds of cases of acute and chronic pancreatitis, according to data from the medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA). These cases are not confirmed as having been caused by the medicines, but the person who reported them suspected they might be. They include 181 reported cases of acute and chronic pancreatitis linked to tirzepatide - the active ingredient for Mounjaro - and five of those people died. Some 116 reported reactions of this kind were linked to liraglutide, one of which was fatal, while there were 113 cases of acute and chronic pancreatitis linked to semaglutide - the active ingredient for Ozempic and Wegovy - where one person died, and 101 reported reactions of this kind were linked to exenatide, from which three people died. Then there were 52 reported reactions linked to dulaglutide and 11 reported reactions linked to lixisenatide, but no fatalities were linked to either drug. Pancreatitis is the inflammation of the pancreas, a gland located behind the stomach that aids in digestion and blood sugar regulation. In severe cases it can lead to organ failure. Nonetheless, the Yellow Card Biobank project, launched by the MHRA and Genomics England, will see researchers examine whether cases of pancreatitis linked to GLP-1 drugs may be influenced by genetic makeup. The MHRA is calling for those who are taking GLP-1 medicine, who have been admitted to hospital due to acute pancreatitis, to submit a report to its Yellow Card scheme. When a Yellow Card report is received, the MHRA will contact patients to ask if they would be willing to take part in the study. Patients will be asked to submit more information and a saliva sample, which will be assessed to explore whether some people are at a higher risk of acute pancreatitis when taking these medicines due to their genes. GLP-1 agonists can lower blood sugar levels in people living with type 2 diabetes and can also be prescribed to support some people with weight loss. Recent estimates suggest that about 1.5 million people in the UK are taking weight-loss jabs. Health officials have suggested they can help turn the tide on obesity, but have stressed they are not a silver bullet and do come with side effects. Most side effects linked to the jabs are gastrointestinal including nausea, constipation and diarrhoea. And the medical regulator recently warned that Mounjaro may make the oral contraceptive pill less effective in some patients. Dr Alison Cave, the MHRA's chief safety officer, said: 'Evidence shows that almost a third of side effects to medicines could be prevented with the introduction of genetic testing, it is predicted that adverse drug reactions could cost the NHS more than £2.2 billion a year in hospital stays alone.' She added: 'Information from the Yellow Card Biobank will help us to better predict those most at risk of adverse reactions - enabling patients across the UK to receive the safest medicine for them, based on their genetic makeup. 'To help us help you, we're asking anyone who has been hospitalised with acute pancreatitis while taking a GLP-1 medicine to report this to us via our Yellow Card scheme. 'Even if you don't meet the criteria for this phase of the Biobank study, information about your reaction to a medication is always extremely valuable in helping to improve patient safety.' Professor Matt Brown, chief scientific officer of Genomics England, said: ' GLP-1 medicines like Ozempic and Wegovy have been making headlines, but like all medicines there can be a risk of serious side effects. 'We believe there is real potential to minimise these with many adverse reactions having a genetic cause. 'This next step in our partnership with the MHRA will generate data and evidence for safer and more effective treatment through more personalised approaches to prescription, supporting a shift towards an increasingly prevention-focused healthcare system.'
Telegraph
19 minutes ago
- Telegraph
Risky money-saving shortcuts could be behind food poisoning increase
Risky money-saving measures such as eating out-of-date food, turning off fridges and failing to heat up meals may be behind a sharp rise in food poisoning cases. More than 10,000 people tested positive for salmonella in 2024, up 17 per cent from 2023 and the highest annual total since 2007, official figures have revealed. Around one in four cases were in children under 10, with London being the most affected area, the UK Health Security Agency (UKHSA) said. There were also more than 70,000 cases of campylobacter, a similar bacterial illness, amounting to a 17.1 per cent rise on the year before. The gastrointestinal illnesses cause similar symptoms, including diarrhoea, stomach pains and cramps, vomiting and mild fever. Infections can be caused by eating contaminated food such as chicken, meat, eggs, unpasteurised milk products, and raw fruit or vegetables, as well as close contact with infected people and kitchen cross-contamination. Health officials said the reason for the rise in cases was 'likely multifactorial' and that improvements in testing could have led to more cases being identified. Hygiene concerns However, another possible cause is people storing and cooking their food in unsafe ways to save money, according to a UKHSA report. A survey by the Food Standard Agency (FSA), which is working with the UKHSA, found that one in eight adults demonstrated risky behaviours while storing and preparing food in response to cost-of-living pressures. This includes cooking food on a lower heat or not for long enough, turning fridges and freezers to less frigid settings, eating food cold instead of hot, and eating out-of-date food. Around 5 per cent of people also admitted to turning their fridge off to save money, while one in eight did not cook their food properly. Potential contamination from environmental sources such as raw dog food in kitchens could also be partly responsible for the increase in salmonella infections, the report added. The UKHSA said children, the elderly and people with weakened immune systems were particularly vulnerable and should take extra care.
